Synergistic Combination Of Xolair/Omalizumab/E25 With Immunosuppressive Agent
    2.
    发明申请
    Synergistic Combination Of Xolair/Omalizumab/E25 With Immunosuppressive Agent 审中-公开
    Xolair / Omalizumab / E25与免疫抑制剂的协同组合

    公开(公告)号:US20080206237A1

    公开(公告)日:2008-08-28

    申请号:US11814871

    申请日:2006-02-02

    IPC分类号: A61K39/395 A61P37/08

    CPC分类号: A61K39/39566 A61K2300/00

    摘要: The present invention provides a pharmaceutical composition comprising an Anti-IgE Antibody and at least one further immunosuppressive agent, in which the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use.

    摘要翻译: 本发明提供了包含抗IgE抗体和至少一种其它免疫抑制剂的药物组合物,其中活性成分在每种情况下以游离形式或以药学上可接受的盐的形式存在,并且任选地至少一种药学上可接受的 载体 用于同时,分开或顺序使用。